BERApharm GmbH

ATBRA.608942-000

active

Legal Form

GmbH

Founded

22. Juli 2023

Country

Austria

Headquarters

Negrellistraße 1

4650 Lambach

Upper Austria

Austria

Contact

office@berapharm.at

Management

Andreas Atzmannstorfer-Zickermann

Managing Director

Since July 22, 2023

Financials

Year	Revenue	Earnings	Balance Total	Equity Ratio
2024	~300.000 €	~-2.733 €	8.904 €	58.7%
2023	~68.000 €	~-9.543 €	9.384 €	84.8%

Industry

NACE 21.20Manufacture of pharmaceutical preparationsISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Manufacture of pharmaceutical preparations

Raw Data

{
  "id": "bcb97dce-55bd-404f-bb9d-a2d98e2c2486",
  "euId": "ATBRA.608942-000",
  "name": "BERApharm GmbH",
  "legalForm": "GmbH",
  "status": "active",
  "foundationDate": "2023-07-22T00:00:00",
  "vatId": null,
  "hq": {
    "line2": null,
    "street": "Negrellistraße 1",
    "city": "Lambach",
    "zipCode": "4650",
    "state": "Upper Austria",
    "country": "AT",
    "latitude": 48.0902357,
    "longitude": 13.8516831278696
  },
  "contactData": {
    "emails": [
      "office@berapharm.at"
    ],
    "phones": [],
    "websites": [],
    "faxes": []
  },
  "managers": [
    {
      "name": "Andreas Atzmannstorfer-Zickermann",
      "position": "Managing Director",
      "startDate": "2023-07-22T00:00:00",
      "endDate": null
    }
  ],
  "industry": {
    "isic": [
      "2100"
    ],
    "nace": [
      "21.20"
    ],
    "nace2025": [
      "21.20"
    ],
    "naics": [
      "325199",
      "325411",
      "325412",
      "325413",
      "325414",
      "339113"
    ],
    "uksic": [
      "21.20"
    ],
    "wz": []
  },
  "financials": [
    {
      "year": 2023,
      "currency": "EUR",
      "capital": 35000,
      "capitalIsEstimate": false,
      "balanceTotal": 9384.28,
      "balanceTotalIsEstimate": false,
      "earnings": -9543.32,
      "earningsIsEstimate": true,
      "earningsCagr": 0,
      "earningsCagrIsEstimate": false,
      "revenue": 68000,
      "revenueIsEstimate": true,
      "revenueCagr": 0,
      "revenueCagrIsEstimate": false,
      "returnOnSales": -14.03429411764706,
      "returnOnSalesIsEstimate": true,
      "equity": 7956.68,
      "equityIsEstimate": false,
      "equityRatio": 84.78732518637551,
      "equityRatioIsEstimate": false,
      "cash": 9229.68,
      "cashIsEstimate": false,
      "receivables": 154.6,
      "receivablesIsEstimate": false,
      "liabilities": 927.6,
      "liabilitiesIsEstimate": false
    },
    {
      "year": 2024,
      "currency": "EUR",
      "capital": 35000,
      "capitalIsEstimate": false,
      "balanceTotal": 8903.52,
      "balanceTotalIsEstimate": false,
      "earnings": -2733.16,
      "earningsIsEstimate": true,
      "earningsCagr": 0,
      "earningsCagrIsEstimate": false,
      "revenue": 300000,
      "revenueIsEstimate": true,
      "revenueCagr": 341.1764705882353,
      "revenueCagrIsEstimate": true,
      "returnOnSales": -0.9110533333333334,
      "returnOnSalesIsEstimate": true,
      "equity": 5223.52,
      "equityIsEstimate": false,
      "equityRatio": 58.66803241863893,
      "equityRatioIsEstimate": false,
      "cash": 5917.52,
      "cashIsEstimate": false,
      "receivables": 2986,
      "receivablesIsEstimate": false,
      "liabilities": 3005,
      "liabilitiesIsEstimate": false
    }
  ]
}